You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Response-Selective C5a Agonist for the Treatment of Asthma
SBC: Prommune, Inc. Topic: NIAIDDESCRIPTION (provided by applicant): An unmet need in the treatment of allergic asthma is an effective therapeutic strategy that focuses on an underlying cause of the disease rather than merely treating or managing its symptoms. At least one well- accepted underlying contributor to the pathophysiologic expression of asthma is an over-expressed and dysregulated T helper type 2 (Th2)-mediated immun ...
STTR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
A Web-based Multimedia Intervention for Head and Neck Cancer Patients
SBC: TRIAD INTERACTIVE, INC. Topic: NCIDESCRIPTION (provided by applicant): Treatment for head and neck squamous cell carcinoma (HNSCC) often confers considerable functional impairment. As a result, HNSCC patients experience significant decrements in quality of life, high levels of emotional distress, deteriorations in interpersonal relations, and increased social isolation. Studies suggest that psychoeducational interventions can impr ...
STTR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Coils for Human Whole Body Imaging at 7T
SBC: LIFE SERVICES L.L.C. Topic: NIBIBDESCRIPTION (provided by applicant): Currently in 40 luminary labs around the world, 7T MR is proving to be a powerful instrument for imaging the human brain. While the same potential exists for whole-body imaging at 7T, the radiofrequency coil technologyand methods critical to realizing this potential have yet to be developed. In this proposal, we plan to solve this problem by developing the new ...
STTR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Development of Tetrahydrocannabinol Prodrugs for Topical Treatment of Glaucoma
SBC: ElSohly Laboratories, Incorporated Topic: NEIDESCRIPTION (provided by applicant): Currently, FDA approved clinical applications of 9-Tetrahydrocannabinol (THC) include control of nausea and vomiting associated with chemotherapy and for appetite stimulation for AIDS patients suffering from anorexia and wasting syndrome. However, THC also has significant potential in the treatment of glaucoma, the second largest cause of blindness, by dec ...
STTR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Development of Porcine Genetic Models of Atherosclerosis
SBC: Recombinetics, Inc. Topic: NHLBIDESCRIPTION (provided by applicant): Because the cardiovascular anatomy of swine is similar to humans with regard to size, morphology, relative collateral arterial supply, and the presence of a well-developed vasa vasorum, the porcine coronary arterial model is the standard for the preclinical evaluation of endovascular devices. Indeed, a consensus report concerning FDA approval of the stents reco ...
STTR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Optimizing Emergency Aftercare with Mobile Video Prescriptions
SBC: HEALTHEWORKS, LLC Topic: NIMHDDESCRIPTION (provided by applicant): healthEworks' mission is to improve discharge health education for the 100 million patients discharged from U.S. emergency departments (EDs) annually. healthEworks aims to accomplish this goal by creating and distributing Video Prescriptions - concise videos specific to the common discharge diagnoses patients receive in the ED. These videos feature Dr. Chr ...
STTR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
A Device To Quantify Sweat Of Single Sweat Glands To Diagnose Neuropathy
SBC: Neuro Devices, Inc. Topic: NINDSDESCRIPTION (provided by applicant): Neuro Devices, Inc. will construct a dynamic sweat test (DST) for early detection of peripheral neuropathy. Neuropathy is detected by measuring the rate and volume of sweat secreted by single sweat glands (SGs) under the control of sudomotor nerves. The test has a major advantage over other tests of nerve function because SGs are accessible for analysis on ...
STTR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
A synthetic biology library for the Semantic Web
SBC: Clark & Parsia, LLC Topic: NHGRIDESCRIPTION (provided by applicant): The long-term aims of this project are to improve the engineering practices of synthetic biologists, and thereby to hasten the pace of synthetic biology research. Synthetic biology is poised to make great contributions to health, medicine, energy, and the environment by building systems ranging from the production of anti-malarial drugs, to improved antibiotics ...
STTR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health -
Survey and Test Platform for Use in Underserved Populations
SBC: ADVANCED MEDICAL ELECTRONICS CORP Topic: NEIDESCRIPTION (provided by applicant): Under the acronym Survey and Test Platform for use in Underserved Populations, Phase II (STeP- UP2), Advanced Medical Electronics Corp, in collaboration with the Johns Hopkins University School of Medicine and several secondary partners, proposes to expand the prototype hardware/software platform called STeP-UP created in the first phase of this STTR project. W ...
STTR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health -
Development of nucleic acid delivery platform based on polymeric CXCR4 antagonists
SBC: Bohemica Pharmaceuticals, LLC Topic: 100DESCRIPTION provided by applicant Therapeutics based on nucleic acids NA promise to revolutionize treatment of multiple diseases but their widespread use is currently limited by the lack of efficient delivery methods We have recently developed a new NA delivery platform based on polymeric CXCR inhibitors PCX suitable as dual function systems for simultaneous NA delivery and inhibition of ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health